Literature DB >> 25859471

Strategy to Increase Awareness and Involvement of Private Medical Practitioners in RNTCP in Taluka Rahata of District Ahmednagar.

Sachin Bhaskar Palve1, Suchitra Balasaheb Parkhad2, Vaishali Deepak Phalke3, Deepak Baburao Phalke3.   

Abstract

BACKGROUND: The global annual incidence of Tuberculosis (TB) is 9 million cases of which estimated 2.3 million cases occur in India. In many parts of India, the private sector has remained alienated from Directly Observed Treatment Short course (DOTS) implementation; hence, case detection has remained low. The performance of Taluka Rahata in terms of TB control was poorest before the year 2000; RNTCP was started in Taluka Rahata on 24th March 2001. From 2001-2010, there was improvement in the performance but was not satisfactory. Hence, present study is an attempt to devise strategy, to increase awareness and involvement of private practitioners in Revised National TB Control Programme in a rural area of Rahata Taluka. AIM: To adopt strategies to improve the awareness and increase involvement of Private Practitioners about RNTCP in Rahata Taluka of Ahmednagar district. SETTING &
DESIGN: It is an Interventional study conducted in Rahata Taluka of District Ahmednagar from June to November by giving personal visits to all the Private Medical Practitioners of Rahata Taluka at their workplace.
MATERIALS AND METHODS: Personal visit was given to 143 private medical practitioners at their workplace. Workshop used as the major strategy was arranged as per RNTCP guidelines. Health education material was distributed.
RESULTS: Out of the 148 PMPs, 143 could be covered by giving personal visits to their clinic for pre-interventional assessment.110 (76.93%) were males while 33 (23.07%) were females. The mean age of PMPs was 41.60 y. Around 60 percentages of PMPs were non- allopathic practitioners. Sensitization workshop was attended by 132 PMPs. Though no significant difference was observed in their assessment regarding etiology about TB, a significant and highly significant value was obtained after assessing their KAP regarding their diagnosis & referral for sputum diagnosis, categorization and treatment, DOTS provider and TB case management.
CONCLUSION: The PMPs due to its non-involvement and non-reinforcement are lagging with the update knowledge. The PMPs who have attained their higher qualification before implementation of RNTCP (before year 2001) are in majority unaware of RNTCP Recommendations: Public-Private partnership involving PMPs & private hospitals need to be strengthened by additional inputs in the form of incentives, free IEC materials and periodic modular training in RNTCP.

Entities:  

Keywords:  DOTS; Private medical practitioners; RNTCP; Tuberculosis

Year:  2015        PMID: 25859471      PMCID: PMC4378753          DOI: 10.7860/JCDR/2015/10724.5523

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  3 in total

1.  Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh.

Authors:  M A Hamid Salim; Mukund Uplekar; Paul Daru; Maug Aung; E Declercq; Knut Lönnroth
Journal:  Bull World Health Organ       Date:  2006-06-21       Impact factor: 9.408

2.  Tuberculosis patients and practitioners in private clinics in India.

Authors:  M Uplekar; S Juvekar; S Morankar; S Rangan; P Nunn
Journal:  Int J Tuberc Lung Dis       Date:  1998-04       Impact factor: 2.373

3.  Tuberculosis suspicion and knowledge among private and public general practitioners: Questionnaire Based Study in Oman.

Authors:  Abdullah A Al-Maniri; Omar A Al-Rawas; Fatmah Al-Ajmi; Ayesha De Costa; Bo Eriksson; Vinod K Diwan
Journal:  BMC Public Health       Date:  2008-05-26       Impact factor: 3.295

  3 in total
  1 in total

Review 1.  From habits of attrition to modes of inclusion: enhancing the role of private practitioners in routine disease surveillance.

Authors:  Revati K Phalkey; Carsten Butsch; Kristine Belesova; Marieke Kroll; Frauke Kraas
Journal:  BMC Health Serv Res       Date:  2017-08-25       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.